Filing Details
- Accession Number:
- 0001181431-13-041156
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-23 19:08:32
- Reporting Period:
- 2013-07-23
- Filing Date:
- 2013-07-23
- Accepted Time:
- 2013-07-23 19:08:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1302573 | Oncomed Pharmaceuticals Inc | OMED | Pharmaceutical Preparations (2834) | 383572512 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1553356 | W. James Broderick | C/O Oncomed Pharmaceuticals, Inc. 800 Chesapeake Drive Redwood City CA 94063 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-23 | 710,526 | $0.00 | 710,526 | No | 4 | C | Indirect | Morgenthaler Partners VII, L.P. |
| Common Stock | Acquisiton | 2013-07-23 | 834,732 | $0.00 | 1,545,258 | No | 4 | C | Indirect | Morgenthaler Partners VII, L.P. |
| Common Stock | Acquisiton | 2013-07-23 | 893,825 | $0.00 | 2,439,083 | No | 4 | C | Indirect | Morgenthaler Partners VII, L.P. |
| Common Stock | Acquisiton | 2013-07-23 | 70,588 | $17.00 | 2,509,671 | No | 4 | P | Indirect | Morgenthaler Partners VII, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | Morgenthaler Partners VII, L.P. |
| No | 4 | C | Indirect | Morgenthaler Partners VII, L.P. |
| No | 4 | C | Indirect | Morgenthaler Partners VII, L.P. |
| No | 4 | P | Indirect | Morgenthaler Partners VII, L.P. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2013-07-23 | 710,526 | $0.00 | 710,526 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2013-07-23 | 834,732 | $0.00 | 834,732 | $0.00 |
| Common Stock | Series B-1 Preferred Stock | Disposition | 2013-07-23 | 893,825 | $0.00 | 893,825 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series A, Series B and Series B-1 Preferred Stock automatically converted on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering on July 23, 2013.
- Morgenthaler Management Partners VII, L.L.C. is the general partner of Morgenthaler Partners VII, L.P. James W. Broderick, a member of Morgenthaler Management Partners VII, L.L.C., disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- The securities are immediately convertible.
- The expiration date is not relevant to the conversion of these securities.
Billionaire Hedge Funds
